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S U M M A R Y
Background: A paradoxical reaction (PR) during anti-tuberculosis treatment is a phenomenon that is
poorly studied in immunocompetent children. It is deﬁned as a clinical or radiological worsening of pre-
existing tuberculosis (TB) disease.
Methods: A retrospective descriptive study of children younger than 14 years of age was performed;
these children developed PR during the years 2009 to 2014, following a diagnosis of TB. Demographic
characteristics, microbiological results, treatment and outcome data were collected.
Results: Of 51 children diagnosed with TB, ﬁve (9.8%) developed a PR; four of these children had
pulmonary TB and the remaining patient had miliary TB with central nervous system involvement. The
PR occurred at a median of 42 days (range 23–53 days) after initiating therapy. Corticosteroids were
started when PR was suspected, at a median dose of 1 mg/kg/day. Clinical and radiological improvement
was noted in all cases, with a median clinical regression time of 10.5 days (range 3–15 days) and a
median radiological regression time of 45 days (range 26–105 days). No sequelae were described in any
patient.
Conclusions: PR in immunocompetent children during anti-tuberculosis treatment is not such an
unusual reaction. Treatment with corticosteroids may be useful for the resolution of PR.
 2016 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
Patients with tuberculosis (TB) can suffer an unexpected
deterioration despite good therapeutic compliance. This phenom-
enon is known as paradoxical reaction (PR), deﬁned as the clinical
or radiological worsening experienced by patients with good
adherence to treatment.1 Such a reaction has been described
extensively in HIV-positive patients, i.e. the immune reconstitu-
tion inﬂammatory syndrome (IRIS). Likewise, the emergence of PR
has also been observed in the immunocompetent population.2
With regard to children, PR has mostly been reported in isolated
clinical cases,3,4 and only two studies have been published to
date.5,6 This article reports the cases of immunocompetent
paediatric patients diagnosed with TB who developed PR over a
period of 5 years.* Corresponding author.
E-mail address: bcarazo002@gmail.com (B. Carazo Gallego).
http://dx.doi.org/10.1016/j.ijid.2016.08.009
1201-9712/ 2016 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).2. Patients and methods
A retrospective descriptive study was performed of patients
under 14 years of age diagnosed with TB who developed a PR; these
patients presented to the study tertiary care hospital during the
years 2009 to 2014.
PR was deﬁned as a clinical or radiological worsening of pre-
existing TB lesions or the development of new lesions, in a patient
who had initiated TB treatment at least 2 weeks before and in
whom a clinical improvement had been observed. The diagnosis of
the PR was made during outpatient visits. The exclusion of a
bacterial or viral infection, poor compliance to treatment, and
resistance to the therapeutic drugs used was required for the
diagnosis.1,7
The time to onset of the PR was considered as the number of
days between the initiation of TB treatment and the diagnosis of
PR. The time for PR regression was deﬁned as the number of days
between the diagnosis of PR and the ﬁrst signs of clinical or
radiological improvement.ciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
T
a
b
le
1
C
h
a
ra
ct
e
ri
st
ic
s
o
f
p
a
e
d
ia
tr
ic
p
a
ti
e
n
ts
w
it
h
T
B
w
h
o
d
e
v
e
lo
p
e
d
a
p
a
ra
d
o
x
ic
a
l
re
a
ct
io
n
P
a
ti
e
n
t
T
B
fo
rm
A
g
e
,
y
e
a
rs
S
e
x
Is
o
la
ti
o
n
o
f
M
T
T
B
re
g
im
e
n
R
a
d
io
lo
g
y
a
t
d
ia
g
n
o
si
s
P
R
o
n
se
t,
d
a
y
s
P
R
sy
m
p
to
m
s
P
R
ra
d
io
lo
g
y
P
R
tr
e
a
tm
e
n
t
D
o
sa
g
e
,
m
g
/k
g
/
d
a
y
S
te
ro
id
s
d
u
ra
ti
o
n
,
d
a
y
s
P
R
cl
in
ic
a
l
re
g
re
ss
io
n
,
d
a
y
s
P
R
ra
d
io
lo
g
ic
a
l
re
g
re
ss
io
n
,
d
a
y
s
1
P
u
lm
o
n
a
ry
2
.3
F
Y
e
s
6
m
o
n
th
s
H
,R
,Z
,E
P
a
re
n
ch
y
m
a
l
in
ﬁ
lt
ra
ti
o
n
in
ri
g
h
t
u
p
p
e
r
lo
b
e
4
2
N
o
W
o
rs
e
n
in
g
o
f
p
a
re
n
ch
y
m
a
l
in
ﬁ
lt
ra
ti
o
n
P
re
d
n
is
o
lo
n
e
1
.5
3
4
-
3
8
2
P
u
lm
o
n
a
ry
2
.1
M
N
o
a
6
m
o
n
th
s
H
,R
,Z
,E
U
n
k
n
o
w
n
5
0
Fe
v
e
r,
co
u
g
h
,
a
n
d
re
sp
ir
a
to
ry
fa
il
u
re
H
il
a
r
a
d
e
n
o
p
a
th
y
;
ri
g
h
t
u
p
p
e
r
lo
b
e
in
ﬁ
lt
ra
ti
o
n
;
b
ro
n
ch
ia
l
co
m
p
re
ss
io
n
P
re
d
n
is
o
lo
n
e
1
1
0
9
3
1
0
5
3
P
u
lm
o
n
a
ry
2
.6
M
Y
e
s
6
m
o
n
th
s
H
,R
,Z
,E
R
ig
h
t
p
a
ra
ca
rd
ia
c
in
ﬁ
lt
ra
ti
o
n
4
2
W
o
rs
e
n
in
g
co
u
g
h
M
id
d
le
lo
b
e
a
te
le
ct
a
si
s
P
re
d
n
is
o
lo
n
e
1
.5
3
3
1
5
2
6
4
P
u
lm
o
n
a
ry
1
.6
M
Y
e
s
6
m
o
n
th
s
H
,R
,Z
,E
P
a
re
n
ch
y
m
a
l
in
ﬁ
lt
ra
ti
o
n
in
ri
g
h
t
u
p
p
e
r
lo
b
e
(F
ig
u
re
1
)
2
3
Fe
v
e
r
a
n
d
co
u
g
h
R
ig
h
t
u
p
p
e
r
a
n
d
m
id
d
le
lo
b
e
a
te
le
ct
a
si
s
(F
ig
u
re
2
)
P
re
d
n
is
o
lo
n
e
1
2
3
6
4
5
5
M
e
n
in
g
it
is
7
.2
M
Y
e
s
1
2
m
o
n
th
s
H
,R
,Z
,E
C
T
ch
e
st
:
m
il
ia
ry
p
a
tt
e
rn
B
ra
in
M
R
I:
su
p
ra
te
n
to
ri
a
l
a
n
d
in
fr
a
te
n
to
ri
a
l
tu
b
e
rc
u
lo
m
a
s
5
3
Fe
v
e
r
re
cu
rr
e
n
ce
In
cr
e
a
se
in
n
u
m
b
e
r
a
n
d
si
ze
o
f
tu
b
e
rc
u
lo
m
a
s
P
re
d
n
is
o
n
e
1
3
0
1
5
7
5
T
B
,
tu
b
e
rc
u
lo
si
s;
M
T
,
M
y
co
b
a
ct
er
iu
m
tu
b
er
cu
lo
si
s;
P
R
,
p
a
ra
d
o
x
ic
a
l
re
a
ct
io
n
;
F,
fe
m
a
le
;
M
,
m
a
le
;
H
,
is
o
n
ia
zi
d
;
R
,
ri
fa
m
p
ic
in
;
Z
,
p
y
ra
zi
n
a
m
id
e
;
E
,
e
th
a
m
b
u
to
l;
C
T
,
co
m
p
u
te
d
to
m
o
g
ra
p
h
y
;
M
R
I,
m
a
g
n
e
ti
c
re
so
n
a
n
ce
im
a
g
in
g
.
a
T
h
is
ca
se
w
a
s
e
x
p
o
se
d
to
a
co
n
ﬁ
rm
e
d
T
B
ca
se
,
in
w
h
ic
h
n
o
re
si
st
a
n
ce
w
a
s
o
b
se
rv
e
d
.
B. Carazo Gallego et al. / International Journal of Infectious Diseases 51 (2016) 15–18163. Results
During the study period, 51 children were diagnosed with TB
disease; none had congenital or acquired immunosuppression.
Five of these patients matched the deﬁnition of PR (9.8%): four had
pulmonary TB and the remaining one had miliary TB with central
nervous system involvement. All patients were autochthonous and
Caucasian. The characteristics of these patients are detailed in
Table 1.
The TB disease was treated with ﬁrst-line drugs in all cases, and
no adverse reaction was observed. The PR occurred at a median of
42 days (range 23–53 days) after the initiation of anti-tuberculosis
drugs. The diagnosis was made on the basis of radiological
worsening in all cases, as well as clinical deterioration in four cases.
Of those with the pulmonary forms, two required admission at
the time of PR and received systemic antibiotics for a suspected
associated bacterial infection; there was no improvement after
initiating the antibiotics and no microbiological isolation in either
case .
The same TB treatment was maintained for all patients, and
systemic corticosteroids were administered in every case for an
average duration of 46 days (range 23–109 days) at a median dose
of 1 mg/kg/day, which was gradually tapered off. A clinical and
radiological improvement was noted in all cases following
corticosteroid treatment. The median clinical regression time
was 10.5 days (range 3–15 days) and the median radiological
regression time was 45 days (range 26–105 days). There were no
sequelae after treatment completion.
To investigate possible predictors of deterioration, patients who
developed PR were compared with those who continued to
improve. No statistically signiﬁcant difference was found for any of
the parameters analyzed (Table 2).
4. Discussion
Although PR is poorly described in the paediatric population,
Thampi et al. reported an incidence of 14% among 112 children
with TB in Canada,5 and Olive et al. reported an incidence of 10% in
130 patients in Belgium.6 In the present study, 9.8% of the children
with TB developed a PR, consistent with the results of these
previous studies.
The pathophysiology of PR in the immunocompetent popula-
tion remains unclear . It has been proposed that in the initial
moments of infection, the bacillus is phagocytosed by lung
macrophages; the triggering of a bactericidal reaction is therefore
avoided, favouring a certain state of immunosuppression. An
increase in production of interleukin 10 (IL-10) and transforming
growth factor beta (TGF-b), which induces the apoptosis of T
lymphocytes and reduces the production of interferon gamma
(IFN-g) , decreases the recruitment of new macrophages and
promotes this level of immunosuppression. After the initiation of
treatment, the immune system improves, either as a consequence
of the therapy or spontaneously, and this is the main cause of TB
worsening .2,8
The two previous studies conducted in children analysed the
risk factors for developing PR.5,6 The main risk factors identiﬁed
were a weight below the 25th percentile, the involvement of more
than one site at initial presentation, and the presence of more
serious symptoms at diagnosis. Olive et al. also described a lower
age at diagnosis as an independent factor.6 The risk factors
analyzed in the present sample were found not to be statistically
signiﬁcant, probably due to the small sample size.
A change in the anti-tuberculosis therapy used, or in the
duration of this therapy, is not recommended during the treatment
of PR. The use of corticosteroids has been proposed by several
authors, with different results obtained.3,4,6 Although there is no
Table 2
Baseline characteristics of the patientsa
No paradoxical
reaction
(n = 46)
Paradoxical
reaction
(n = 5)
p-Value
Median age, years 4.5 (0.1–13.9) 2.6 (1.6–7.2) 0.46
<3 years of age 16 (34.7%) 3 (6.5%) 0.34
Male to female ratio 25/21 3/2 1.00
Weight percentile 25% 16 (34.7%) 2 (40%) 1.00
History of TB contact 22 (47.8%) 1 (20%) 0.35
TST median, mm 12 11.5 0.79
Negative 5 (10.8%) 0 1.00
5–14 mm 28 (60.8%) 4 (80%) 0.64
15 mm 13 (28.4%) 1 (20%) 1.00
Pulmonary TB 31 (67.3%) 4 (80%)
Extrapulmonary TB 15 (32.7%) 1 (20%) 1.00
Endobronchial 3 0
Pleural 2 0
Disseminated 4 0
Lymph node 3 0
Abdominal 1 0
Meningeal 2 1
Mycobacterium
tuberculosis-positive
culture
21 (45.6%) 4 (80%) 0.19
Median lymphocyte
count, 109/l
3.120
(0.200–11.900)
3.150
(0.120–5.870)
1.00
Cases with lymphocyte
count <1.5 109/l
5 (10.8%) 1 (20%) 0.42
Median haemoglobin
level, g/dl
11.9 (7–13.5) 11.2 (9.3–13.5) 0.76
Median treatment
duration, months
6 (6–12) 6 (6–12) 0.83
Number of cases with
steroid treatment
6 (13%) 5 (100%) <0.001
TB, tuberculosis; TST, tuberculin skin test.
a Data are presented as number (%) or median (range). The statistical analysis was
done using the Student t-test or Mann–Whitney U-test for medians and proportions,
according to the variable distribution. Categorical variables were compared using
Fisher’s exact test. The conﬁdence interval was 95%.
Figure 2. Chest X-ray done in the same patient (patient 4, Table 1) at the time of
diagnosis of the paradoxical reaction: a radiological worsening with an increase in
parenchymal inﬁltration and atelectasis in the right upper and middle lobes can be
seen.
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be sufﬁcient in mild cases and that steroids could be beneﬁcial for
severe forms.2,9,10 With regard to the dose used, most studies have
recommended an initial dose of 1 mg/kg/day, with a progressive
tapering off over 4 or 6 weeks.2–4,9
Corticosteroid treatment was given to all of the patients in this
study, with good results. Some of them did not present with aFigure 1. Chest X-ray done at diagnosis of pulmonary tuberculosis in a 2-year-old
boy (patient 4, Table 1), showing a right upper lobe inﬁltration. .severe form of PR; therefore, it is possible that their outcomes
would have been equally successful without corticosteroid
treatment.
This study has several limitations. It was retrospective in design
and included a small patient sample. Furthermore, one patient in
whom Mycobacterium tuberculosis was not isolated was included
among those with PR, as the bacillus was isolated in the index case
Figures 1 and 2.
In conclusion, PR is not such an unusual occurrence in
immunocompetent children with TB. It is important to consider
PR when other causes of clinical or radiological worsening have
been ruled out.
Funding: None.
Conﬂict of interest: The authors have no conﬂicts of interest to
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